Inhibition of matrix metalloproteinase activity in the chick sclera and its effect on myopia development

To investigate the contribution of matrix degradation in the two-layer avian sclera to the development of myopia. Tissue inhibitor of metalloproteinase-2 (TIMP-2) was used to inhibit chick scleral collagen degradation with (3)H-proline, a marker for this effect. Ex vivo scleral culture experiments confirmed TIMP-2 doses for in vivo experimentation. Ocular growth and refractive response to exogenous TIMP-2 (11.25, 2.25, and 0.45 picomoles, plus vehicle only) were monitored in 7-day-old chicks during the induction of myopia over 4 days with a translucent occluder. Collagen degradation was assessed, in whole sclera and in separated scleral layers by using the same paradigm (11.25 picomoles TIMP-2; vehicle only).Approximately 60% of collagen degradation was inhibited with low (2 nM) doses of TIMP-2 in the ex vivo sclera. Degradative activity in the in vivo chick sclera increased significantly (46%) during myopia development, with all the altered activity confined to the fibrous layer. Addition of TIMP-2 significantly reduced (by 46%) this accelerated scleral collagen degradation, also by acting in the fibrous layer. TIMP-2 had no significant effect on (3)H-proline incorporated in the cartilaginous scleral layer and cornea. Despite inhibiting collagen degradation TIMP-2 had no significant effect on myopia development. Increased collagen degradation is a feature of scleral remodeling in chick myopia development, but is confined to the fibrous scleral layer. Significant inhibition of this collagenolytic activity with TIMP-2 has little effect on refractive error development, suggesting that collagen degradation in the sclera contributes little to the development of myopia in the chick.

Myopia : why study the mechanisms of myopia? Novel approaches to risk factors Signaling eye growth- how could basic biology be translated into clinical insights? Where are genetic and proteomic approaches leading? How does visual function contribute to an

On July 26–29, 2010 the 13th International Myopia Conference was held in Tübingen, Germany and included 17 separate symposia, each with 3–5 presentations. Here, in a single paper, the chairs of those Symposia describe the scientific advances noted at the conference and include the full abstracts of the individual myopia papers presented in each symposium along with the authors and their institutions. The 17 Symposia covered 7 topics: Why Study the Mechanisms of Myopia?; Novel Approaches to Risk Factors; Signaling Eye Growth- How Could Basic Biology Be Translated into Clinical Insights?; Where Are Genetic and Proteomic Approaches Leading?; How Does Visual Function Contribute to and Interact with Ametropia?; Does Eye Shape Matter?; Why Ametropia at All?

Prevalence of Myopia in adults: implications for refractive surgeons

BACKGROUND: We reviewed the research on the prevalence of myopia in the adult population to compare the refractive distribution of patients being treated with excimer laser photorefractive keratectomy to correct myopia, and assess the potential market for excimer laser surgery. METHODS: All published reports of myopia prevalence in adults were reviewed, as well as the prevalence in the Melbourne Visual Impairment Project and the distribution of refractive errors treated by the Melbourne Excimer Laser Group in 1994. RESULTS: A large population-based study of people aged 4 to 74 years in the U.S. showed that 43% had low myopia (less than -5.00 diopters (D)), 3.2% had high myopia (-5.01 to -10.00 D), and 0.2% had extreme myopia (more than -10.00 D). In Asian populations these proportions may be much higher and in African and Pacific island groups, much lower. In the Melbourne Visual Impairment Project, we found the prevalence of low myopia was 21%, high myopia 2%, and extreme myopia 0.3%. A single excimer laser has operated for 3 years in Melbourne. Of those treated, 45% had low myopia, 42% high myopia, and 13% extreme myopia. Compared to low myopes, high myopes were ten times (OR: 9.8; Confidence interval: 6.69 to 12.91) more likely to have excimer laser treatment and extreme myopes were 16 times (OR: 16.40; Confidence interval: 12.53 to 20.27) more likely. CONCLUSIONS: Although there are many more people with lower amounts of myopia in the population and the clinical results have been more predictable after one procedure in this group, the perceived benefits of excimer laser treatment may be greater for those with higher amounts of myopia, thus influencing their decision to undergo excimer laser surgery to correct their myopia. There is clearly a large market potential for excimer laser surgery in people with low myopia.

Bilateral central crystalline corneal deposits four years after intacs for myopia

PURPOSE: To report a case of bilateral central crystalline keratopathy in the anterior stroma occurring 4 years after Intacs implantation. METHODS: A 45-year-old woman underwent bilateral uncomplicated Intacs implantation for myopia. The postoperative course was uneventful. However, between 3 and 4 years after surgery, the patient developed central opacifications of the anterior stroma in both eyes, reducing best spectacle-corrected visual acuity. RESULTS: Intacs were explanted. Confocal microscopy, electron microscopy of the explanted ring segments, and microbiology studies were performed. Opacities were still detectable at the slit-lamp microscope up to 8 months after explantation. CONCLUSIONS: This is the first report on central corneal opacifications after Intacs implantation for myopia. The opacities could be the result of chronic metabolic stress or the beginning of lipid-like changes in another more central corneal localization.